IRIS
ROGLIANI, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.438
NA - Nord America 1.463
EU - Europa 733
SA - Sud America 586
AF - Africa 162
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.394
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.396
SG - Singapore 1.031
BR - Brasile 441
VN - Vietnam 402
CN - Cina 371
HK - Hong Kong 276
IT - Italia 219
IE - Irlanda 117
ZA - Sudafrica 113
BD - Bangladesh 112
FR - Francia 86
IN - India 78
NL - Olanda 71
AR - Argentina 46
RU - Federazione Russa 39
DE - Germania 33
SE - Svezia 33
GB - Regno Unito 32
MX - Messico 32
AT - Austria 30
CO - Colombia 22
CA - Canada 21
EC - Ecuador 20
IQ - Iraq 18
VE - Venezuela 16
PY - Paraguay 15
TR - Turchia 15
JP - Giappone 14
MA - Marocco 14
PL - Polonia 14
CL - Cile 12
ID - Indonesia 12
PK - Pakistan 12
TH - Thailandia 12
ES - Italia 10
UA - Ucraina 10
AE - Emirati Arabi Uniti 9
UZ - Uzbekistan 9
AU - Australia 8
MY - Malesia 8
CI - Costa d'Avorio 7
SA - Arabia Saudita 7
AZ - Azerbaigian 6
DZ - Algeria 6
KR - Corea 6
LT - Lituania 6
PH - Filippine 6
PT - Portogallo 6
CH - Svizzera 5
EG - Egitto 5
PE - Perù 5
TW - Taiwan 5
BO - Bolivia 4
IL - Israele 4
JM - Giamaica 4
TN - Tunisia 4
UY - Uruguay 4
BE - Belgio 3
BW - Botswana 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
FI - Finlandia 3
HN - Honduras 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
GR - Grecia 2
HR - Croazia 2
HU - Ungheria 2
IR - Iran 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
KW - Kuwait 2
KZ - Kazakistan 2
LB - Libano 2
LV - Lettonia 2
NP - Nepal 2
OM - Oman 2
SN - Senegal 2
SY - Repubblica araba siriana 2
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CZ - Repubblica Ceca 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MR - Mauritania 1
NG - Nigeria 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SV - El Salvador 1
TJ - Tagikistan 1
Totale 5.393
Salva come PNG Salva come JPEG
Città #
Singapore 482
San Jose 317
Ashburn 285
Hong Kong 267
Santa Clara 152
Ho Chi Minh City 140
Dublin 117
Johannesburg 99
Beijing 98
Hanoi 88
Dallas 80
Lauterbourg 68
Los Angeles 55
New York 55
Rome 41
Boardman 39
Council Bluffs 29
São Paulo 29
Milan 28
Moscow 23
Buffalo 20
Vienna 20
Da Nang 18
Mexico City 18
Chicago 17
Shanghai 15
Haiphong 14
Naples 14
Parma 14
Rio de Janeiro 14
Nuremberg 12
Warsaw 12
Hải Dương 11
Tianjin 11
Biên Hòa 10
Frankfurt am Main 10
Hefei 10
Medellín 10
St Louis 10
Belo Horizonte 9
Marseille 9
Tashkent 9
Bengaluru 8
Brooklyn 8
Columbus 8
London 8
Salvador 8
Abidjan 7
Ankara 7
Bologna 7
Chandler 7
Chennai 7
Denver 7
Kolkata 7
Ninh Bình 7
Quito 7
Sydney 7
Baku 6
Curitiba 6
Dhaka 6
Duque de Caxias 6
Mumbai 6
Orem 6
Porto Alegre 6
Redondo Beach 6
Tokyo 6
Toronto 6
Asunción 5
Atlanta 5
Brasília 5
Bắc Ninh 5
Caracas 5
Casablanca 5
Florence 5
Kuala Lumpur 5
Philadelphia 5
Phoenix 5
Wuhan 5
Zurich 5
Baghdad 4
Bangkok 4
Bogotá 4
Buenos Aires 4
Campinas 4
Charlotte 4
Fortaleza 4
Goiânia 4
Guangzhou 4
Houston 4
Hưng Yên 4
Joinville 4
La Plata 4
Montevideo 4
Munich 4
Reggio Emilia 4
Ribeirão Preto 4
Riyadh 4
San Francisco 4
Seattle 4
Shenyang 4
Totale 3.093
Salva come PNG Salva come JPEG
Nome #
The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma 133
A single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol for the treatment of COPD 119
The Impact of Thermal Water in Asthma and COPD: A Systematic Review According to the PRISMA Statement 116
The 5T approach in asthma: Triple Therapy Targeting Treatable Traits 115
Stem Cell-Based Regenerative Therapy and Derived Products in COPD: A Systematic Review and Meta-Analysis 105
Impact of Sex on Proper Use of Inhaler Devices in Asthma and COPD: A Systematic Review and Meta-Analysis 103
Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS Score 100
An update on the currently available and emerging synthetic pharmacotherapy for uncontrolled asthma 93
A comprehensive overview of investigational elastase inhibitors for the treatment of acute respiratory distress syndrome 90
Advances in adrenergic receptors for the treatment of chronic obstructive pulmonary disease: 2023 update 90
Investigational anti IL-13 asthma treatments: a 2023 update 89
Investigational Treatments in Phase I and II Clinical Trials: A Systematic Review in Asthma 88
A narrative review on asthma and pest sensitization (cockroach, mouse and rat allergens): a social issue besides the medical problem 87
The interplay between asthma and type 2 diabetes mellitus: mutual interactions and therapeutic implications 86
Advances in inhaled corticosteroids for the treatment of chronic obstructive pulmonary disease: what is their value today? 86
Bayesian or frequentist: there is no question when comparing single-inhaler triple therapies via network meta-analysis. Focus on fluticasone furoate/umeclidinium/vilanterol fixed-dose combination in chronic obstructive pulmonary disease 85
Inflammatory and contractile profile in LPS-challenged equine isolated bronchi: Evidence for IL-6 as a potential target against AHR in equine asthma 84
Asthma and comorbidities: recent advances 84
Assessing the relationship between cardiovascular and small airway disease and acute events in COPD: The ARCADIA study protocol 82
Impact of Airway-Occluding Mucus Plugs on Mortality in Patients with COPD According to Disease Severity: A Subset Analysis of Data From COPDGene 81
Asthma management with triple ICS/LABA/LAMA combination to reduce the risk of exacerbation: an umbrella review compliant with the PRIOR statement 80
Beclomethasone dipropionate and sodium cromoglycate protect against airway hyperresponsiveness in a human ex vivo model of cow's milk aspiration 78
Delivering monoclonal antibodies via inhalation: a systematic review of clinical trials in asthma and COPD 77
Challenges in treating patients with comorbid asthma and bronchiectasis 77
Expert guidance on the management and challenges of long-COVID syndrome: a systematic review 76
Biologics for asthma and risk of pneumonia 75
Drug-Drug Interactions and Synergy: From Pharmacological Models to Clinical Application 74
Muscarinic receptor antagonists and airway inflammation: A systematic review on pharmacological models 73
Beyond Dual Bronchodilation - Triple Therapy, When and Why 73
Efficacy of respiratory tele-rehabilitation in COPD patients: Systematic review and meta-analysis 72
Investigational thymic stromal lymphopoietin inhibitors for the treatment of asthma: a systematic review 72
Cardiovascular diseases or type 2 diabetes mellitus and chronic airway diseases: mutual pharmacological interferences 71
The discovery and development of gefapixant as a novel antitussive therapy 69
Cardiovascular Events with the Use of Long-Acting Muscarinic Receptor Antagonists: An Analysis of the FAERS Database 2020–2023 69
Clinical characteristics, treatment patterns and adherence in patients with asthma on multiple inhaler triple therapy: a review of findings 68
Clinical Interpretation of Efficacy Outcomes in Pharmacological Studies on Triple Fixed-Dose Combination Therapy for Uncontrolled Asthma: Assessment of IRIDIUM and ARGON Studies 67
The Impact of Corticosteroids on Human Airway Smooth Muscle Contractility and Airway Hyperresponsiveness: A Systematic Review 66
Real-World Effectiveness of Triple Extrafine Fixed-Dose Combination with Beclomethasone/ Formoterol/Glycopyrronium on Symptoms and Lung Function in COPD: A Systematic Review and Meta-Analysis 66
Use of human airway smooth muscle in vitro and ex vivo to investigate drugs for the treatment of chronic obstructive respiratory disorders 65
Asthma and Cardiovascular Diseases: Navigating Mutual Pharmacological Interferences 65
Potential Drawbacks of ICS/LABA/LAMA Triple Fixed-Dose Combination Therapy in the Treatment of Asthma: A Quantitative Synthesis of Safety Profile 64
Inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review and meta-analysis on mortality protection - making a long story short 63
Efficacy and safety of long-acting muscarinic antagonists in COPD: A meta-analysis and meta-regression with a focus on aging 63
Strength of association between comorbidities and asthma: a meta-analysis 63
Cardiovascular Events in Chronic Obstructive Pulmonary Disease: Squeezing ETHOS Dry for Clinical Evidence at Risk of Type I Error 63
Can glucagon-like peptide-1 receptor agonists induce asthma? An analysis of the FAERS database 62
Interaction between fluticasone furoate and umeclidinium in passively sensitized isolated human airways 61
Real-World Efficacy of Biological Therapies in Severe Asthma: A Focus on Small Airways 60
An overview of the efficacy and safety of β2-adrenoceptor antagonists for the treatment of chronic obstructive pulmonary disease 60
Biologic therapies for chronic obstructive pulmonary disease 60
Pharmacological Interpretation of the Efficacy of Ensifentrine in Chronic Obstructive Pulmonary Disease: Insights from ENHANCE Trials 60
Dual bronchodilation for the treatment of COPD: From bench to bedside 59
PI3K Inhibitors as Potential Therapeutic Agents for the Treatment of COPD with Associated Atherosclerosis 59
Drug interaction and chronic obstructive respiratory disorders 59
Emerging Anti-Inflammatory COPD Treatments: Potential Cardiovascular Impacts 59
Experimental drugs in clinical trials for COPD: artificial intelligence via machine learning approach to predict the successful advance from early-stage development to approval 59
The novel inhaled dual PDE3 and PDE4 inhibitor ensifentrine for the treatment of COPD: A systematic review and meta-analysis protocol on trough FEV1 and exacerbation according to PRISMA statement 58
Reducing the risk of death–a possible outcome in COPD patients 56
Doxofylline: Advancing and Empowering Equitable Asthma and COPD Management Beyond Tradition 56
What role will ensifentrine play in the future treatment of chronic obstructive pulmonary disease patients? Implications from recent clinical trials 55
Letter to the Editor Regarding "Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab" 52
Strategies for overcoming the biological barriers associated with the administration of inhaled monoclonal antibodies for lung diseases 51
β-Blockers and Asthma: Surprising findings from the FAERS database 51
Severe Asthma and Biological Therapy: When, Which, and for Whom 51
Clinically Important Deterioration (CID) and Ageing in COPD: A Systematic Review and Meta-Regression Analysis According to PRISMA Statement 50
Systematic literature review of treatments used for refractory or unexplained chronic cough in adults 48
Pest sensitization to cockroach, mouse, and rat: An Italian multicenter study 48
Impact of N-Acetylcysteine on Mucus Hypersecretion in the Airways: A Systematic Review 48
Sex differences in adult asthma and COPD therapy: a systematic review 48
Prescribing the right therapy for the treatment of chronic cough: a critical focus on current and investigational options 47
Characterisation of the novel quinoline RCD405: Relaxant effects on cholinergic and histaminergic tone in human bronchi and small airways 47
Effects of SARS-CoV-2 Infection on Pulmonary Function Tests and Exercise Tolerance 47
The need for inhaled phosphodiesterase inhibitors in chronic obstructive pulmonary disease 46
Dose of Inhaled Corticosteroids and Cardiovascular Disease in Asthma: An Unexpected Misstep? 45
Role of exosomes in exacerbations of asthma and COPD: a systematic review 44
Novel drug discovery strategies for chronic obstructive pulmonary disease: the latest developments 44
Hyperglycaemia and Chronic Obstructive Pulmonary Disease 42
Ensifentrine approval: A milestone in the treatment of COPD 37
Response 35
The future of inhalation therapy in chronic obstructive pulmonary disease 31
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review 30
Totale 5.490
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.312
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.312
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023236 0 4 4 4 25 11 30 20 117 11 7 3
2023/2024214 16 20 17 11 14 23 26 16 21 14 8 28
2024/20251.266 13 36 137 70 105 182 55 63 181 115 81 228
2025/20263.774 352 343 510 408 490 134 401 140 390 282 311 13
Totale 5.490